Clinical Study
Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin
Table 3
Postcesarean thrombosis risk factors.
| Thromboprophylactic regimen | Group A | Group B | (number of cases) | Bemiparin 3500 IU/5 days | Bemiparin 3500 IU/10 days | | () | () |
| Postcesarean anemia () (%) | | | | 222 (71.38%) | 249 (74.32%) | | 161 (51.8%) | 179 (53.5%) | | 72 (23.4%) | 89 (26.6%) | Infection | 21 (6.8%) | 20 (6%) | Seroma | 17 (5.5%) | 16 (4.8%) | Postcesarean hypertension | 15 (5.7%) | 9 (4%) |
|
|
Hb: hemoglobin.
|